Please note – you will leave a website owned by MacroGenics, Inc.
MacroGenics is not responsible for any content on the third party website.
We are a biopharmaceutical company with a mission to develop, manufacture and commercialize innovative monoclonal antibody-based, life-changing medicines to transform the lives of patients with cancer. This requires the application of our expertise in protein engineering and other technical capabilities, the teamwork of our employees and a shared commitment to excellence. Furthermore, we undertake this important mission in the context of building a safe, environmentally responsible and ethical business to make a positive impact on society while providing long-term value for all stakeholders, including our employees, partners, patients, and stockholders.
As part of this commitment, we support ESG (Environmental, Social and Governance) initiatives that are aligned with our Living Values. These values provide the foundation for us to demonstrate our dedication to patients and their caregivers, our staff, environment and local communities. MacroGenics’ senior management team leads our ESG effort with important cross-functional contributions across our company; oversight for this program is further provided by our Board of Directors.
Below is a link to our 2023 Corporate Responsibility report.
